Effect of iodine on early stage thyroid autonomy

Genomics

Volumn 97, Issue 2, 2011, Pages 94-100

  Müller, Kathrin ^a   Krohn, Knut ^b   Eszlinger, Markus ^a   Ludgate, Marian ^c   Führer, Dagmar ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Apoptosis; FRTL 5 cells; Iodine; Iyd; Junb; Thyroid autonomy

Indexed keywords

IODIDE PEROXIDASE; IODINE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SODIUM IODIDE SYMPORTER; THYROID PEROXIDASE; THYROTROPIN RECEPTOR; TRANSCRIPTION FACTOR JUNB;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE CLUSTER; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THYROID AUTONOMY; THYROID DISEASE; UPREGULATION;

ANIMALS; CELL LINE; CELL PROLIFERATION; DOWN-REGULATION; GENES, JUN; IODIDE PEROXIDASE; IODIDES; IODINE; MUTATION; RATS; RECEPTORS, THYROTROPIN; SYMPORTERS; THYROID GLAND; THYROTOXICOSIS; UP-REGULATION;

EID: 79451469492     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2010.10.007     Document Type: Article

References (26)

1. Afink G., Kulik W., Overmars H., de Randamie J., Veenboer T., van Cruchten A., Craen M., Ris-Stalpers C. Molecular characterization of iodotyrosine dehalogenase deficiency in patients with hypothyroidism. J. Clin. Endocrinol. Metab. 2008, 93:4894-4901.
2. Aghini-Lombardi F., Antonangeli L., Martino E., Vitti P., Maccherini D., Leoli F., Rago T., Grasso L., Valeriano R., Balestrieri A., Pinchera A. The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J. Clin. Endocrinol. Metab. 1999, 84:561-566.
3. Al Khafaji F., Wiltshire M., Fuhrer D., Mazziotti G., Lewis M.D., Smith P.J., Ludgate M. Biological activity of activating thyrotrophin receptor mutants: modulation by iodide. J. Mol. Endocrinol. 2005, 34:209-220.
4. Bauch K. Epidemiology of functional autonomy. Exp. Clin. Endocrinol. Diabetes 1998, 106(Suppl 4):S16-S22.
5. Clemens P.C., Neumann R.S. The Wolff-Chaikoff effect: hypothyroidism due to iodine application. Arch. Dermatol. 1989, 125:705.
6. Deleu S., Pirson I., Clermont F., Nakamura T., Dumont J.E., Maenhaut C. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli. J. Cell. Physiol. 1999, 181:342-354.
7. Doyon Y., Cayrou C., Ullah M., Landry A.J., Cote V., Selleck W., Lane W.S., Tan S., Yang X.J., Cote J. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol. Cell 2006, 21:51-64.
8. Eng P.H., Cardona G.R., Fang S.L., Previti M., Alex S., Carrasco N., Chin W.W., Braverman L.E. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 1999, 140:3404-3410.
9. Eszlinger M., Krohn K., Berger K., Lauter J., Kropf S., Beck M., Fuhrer D., Paschke R. Gene expression analysis reveals evidence for increased expression of cell cycle-associated genes and Gq-protein-protein kinase C signaling in cold thyroid nodules. J. Clin. Endocrinol. Metab. 2005, 90:1163-1170.
10. Fuhrer D., Eszlinger M., Karger S., Krause K., Engelhardt C., Hasenclever D., Dralle H., Paschke R. Evaluation of insulin-like growth factor II, cyclooxygenase-2, ets-1 and thyroid-specific thyroglobulin mRNA expression in benign and malignant thyroid tumours. Eur. J. Endocrinol. 2005, 152:785-790.
11. Fuhrer D., Lewis M.D., Alkhafaji F., Starkey K., Paschke R., Wynford-Thomas D., Eggo M., Ludgate M. Biological activity of activating thyroid-stimulating hormone receptor mutants depends on the cellular context. Endocrinology 2003, 144:4018-4030.
12. Gnidehou S., Caillou B., Talbot M., Ohayon R., Kaniewski J., Noel-Hudson M.S., Morand S., Agnangji D., Sezan A., Courtin F., Virion A., Dupuy C. Iodotyrosine dehalogenase 1 (DEHAL1) is a transmembrane protein involved in the recycling of iodide close to the thyroglobulin iodination site. FASEB J. 2004, 18:1574-1576.
13. Gozu H.I., Bircan R., Krohn K., Muller S., Vural S., Gezen C., Sargin H., Yavuzer D., Sargin M., Cirakoglu B., Paschke R. Similar prevalence of somatic TSH receptor and Gsalpha mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey. Eur. J. Endocrinol. 2006, 155:535-545.
14. Gunduz M., Ouchida M., Fukushima K., Ito S., Jitsumori Y., Nakashima T., Nagai N., Nishizaki K., Shimizu K. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers. Oncogene 2002, 21:4462-4470.
15. Laurberg P., Pedersen K.M., Vestergaard H., Sigurdsson G. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J. Intern. Med. 1991, 229:415-420.
16. Leoni S.G., Galante P.A., Ricarte-Filho J.C., Kimura E.T. Differential gene expression analysis of iodide-treated rat thyroid follicular cell line PCCl3. Genomics 2008, 91:356-366.
17. Maier J., van Steeg H., van Oostrom C., Paschke R., Weiss R.E., Krohn K. Iodine deficiency activates antioxidant genes and causes DNA damage in the thyroid gland of rats and mice. Biochim. Biophys. Acta 2007, 1773:990-999.
18. Moreno J.C., Klootwijk W., van Toor H., Pinto G., D'Alessandro M., Leger A., Goudie D., Polak M., Gruters A., Visser T.J. Mutations in the iodotyrosine deiodinase gene and hypothyroidism. N Engl J. Med. 2008, 358:1811-1818.
19. Nishihara E., Amino N., Maekawa K., Yoshida H., Ito M., Kubota S., Fukata S., Miyauchi A. Prevalence of TSH receptor and Gsalpha mutations in 45 autonomously functioning thyroid nodules in Japan. Endocr. J. 2009, 56:791-798.
20. Paschke R., Ludgate M. The thyrotropin receptor in thyroid diseases. N Engl J. Med. 1997, 337:1675-1681.
21. Shapiro L., Fannon A.M., Kwong P.D., Thompson A., Lehmann M.S., Grubel G., Legrand J.F., Als-Nielsen J., Colman D.R., Hendrickson W.A. Structural basis of cell-cell adhesion by cadherins. Nature 1995, 374:327-337.
22. Smerdely P., Pitsiavas V., Boyages S.C. Evidence that the inhibitory effects of iodide on thyroid cell proliferation are due to arrest of the cell cycle at G0G1 and G2M phases. Endocrinology 1993, 133:2881-2888.
23. Smerdely P., Pitsiavas V., Boyages S.C. The G2M arrest caused by iodide is unrelated to the effects of iodide at adenylate cyclase. Thyroid 1995, 5:325-330.
24. Vassart G., Dumont J.E. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr. Rev. 1992, 13:596-611.
25. Vitale M., Di Matola T., D'Ascoli F., Salzano S., Bogazzi F., Fenzi G., Martino E., Rossi G. Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress. Endocrinology 2000, 141:598-605.
26. Wu Q., Maniatis T. A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell 1999, 97:779-790.